Inherited retinal disease: natural history and genetics study
Part of Eyes & vision, Genetic & congenital clinical trials.
This study is for people with inherited retinal diseases. Researchers want to learn how the disease changes over time and how specific gene changes affect vision. You will have eye exams and imaging to track your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Had at least one eye exam and retinal imaging at our center.
- Diagnosed with an inherited retinal disease, like retinitis pigmentosa or Stargardt disease.
- Had a genetic test that found the exact gene change causing your eye condition.
- Do not have other eye diseases like diabetic retinopathy or glaucoma that could affect the results.
- Have not taken medications that can hurt the retina, such as hydroxychloroquine or tamoxifen.
- The cause of your vision loss from a gene change is clear.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how people with inherited retinal disease that affects peripheral vision see and move around. It will test a new way to measure vision and navigation to see if it can help doctors understand how the disease affects daily life.
This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.
This study follows people with Stargardt disease (a genetic eye condition that causes vision loss) over time. It aims to learn more about how the disease progresses and does not test any treatment.
This study observes how Stargardt disease and similar eye conditions change over time in children and adults. It aims to learn more about the disease progression to help develop future treatments.
This trial tests a single injection of a new medicine, RTx-021, into the eye for people with Stargardt disease. The goal is to see if it is safe and to find the right dose.
This study is a registry, meaning it collects information about people with inherited retinal (retina) diseases. It may help researchers learn how these conditions progress and connect you with future studies or treatments.
Hear when a new Stargardt Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.